Rare cancer drugs budget underspent by nearly half

Health Pills

Only 56 per cent of the money allocated for cancer drugs normally unavailable on the NHS was spent in the first six months of a high profile fund, a report has found.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here